Exane Derivatives’s Halliburton HAL Stock Holding History

Exane Derivatives’s Portfolio HAL Stock Details HAL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-9,790	Closed	-$371K	–	859
2022 Q1	$371K	Buy	+9,790	New	+$317K	0.1%	223
2021 Q4	–	Sell	-10,171	Closed	-$220K	–	919
2021 Q3	$220K	Hold	10,171	–	–	0.05%	374
2021 Q2	$225K	Buy	+10,171	New	+$226K	0.05%	366
2020 Q3	–	Sell	-46,615	Closed	-$605K	–	764
2020 Q2	$605K	Buy	46,615 +16,064	+53%	+$173K	0.16%	114
2020 Q1	$209K	Sell	30,551 -114,569	-79%	-$1.99M	0.06%	194
2019 Q4	$3.42M	Sell	145,120 -17,780	-11%	-$375K	0.63%	55
2019 Q3	$3.07M	Sell	162,900 -5,237	-3%	-$108K	0.55%	54
2019 Q2	$3.82M	Buy	168,137 +128,700	+326%	+$3.34M	0.67%	36
2019 Q1	$1.16M	Buy	39,437 +14,601	+59%	+$441K	0.23%	98
2018 Q4	$660K	Buy	+24,836	New	+$838K	0.12%	153
2018 Q3	–	Sell	-1,865	Closed	-$84.3K	–	713
2018 Q2	$84.3K	Buy	+1,865	New	+$92.9K	0.01%	354
2018 Q1	–	Sell	-12,326	Closed	-$602K	–	640
2017 Q4	$602K	Sell	12,326 -2,252	-15%	-$99.3K	0.1%	148
2017 Q3	$671K	Sell	14,578 -19,137	-57%	-$802K	0.13%	112
2017 Q2	$1.44M	Buy	33,715 +17,587	+109%	+$808K	0.31%	74
2017 Q1	$794K	Buy	16,128 +9,682	+150%	+$521K	0.18%	101
2016 Q4	$349K	Sell	6,446 -378	-6%	-$18.8K	0.07%	180
2016 Q3	$306K	Buy	6,824 +1,331	+24%	+$58.1K	0.05%	182
2016 Q2	$249K	Sell	5,493 -36,124	-87%	-$1.49M	0.04%	189
2016 Q1	$1.49M	Sell	41,617 -5,101	-11%	-$166K	0.2%	68
2015 Q4	$1.59M	Buy	+46,718	New	+$1.76M	0.22%	66
2015 Q3	–	Sell	-29,059	Closed	-$1.25M	–	551
2015 Q2	$1.25M	Buy	29,059 +4,336	+18%	+$200K	0.13%	80
2015 Q1	$1.08M	Sell	24,723 -9,233	-27%	-$385K	0.12%	92
2014 Q4	$1.34M	Buy	+33,956	New	+$1.65M	0.19%	86

Other funds holding HAL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Exane Derivatives's HAL Position: Q2 2022 in Review

Exane Derivatives sold out of Halliburton (HAL) in Q2 2022, closing a stake of 9,790 shares — an estimated $371K sold.

Exane Derivatives first reported a position in HAL in Q4 2014 and held it in 23 quarters. The position peaked at $3.82M in Q2 2019. 842 funds tracked by Wall St. Rank hold HAL as of Q2 2022.

Exane Derivatives reported no remaining Halliburton position as of Q2 2022 after selling out during the quarter.
Exane Derivatives sold 9,790 Halliburton shares in Q2 2022, an estimated $371K.
Exane Derivatives first reported a position in Halliburton in Q4 2014 and held it in 23 quarters.
Exane Derivatives's Halliburton position peaked at $3.82M in Q2 2019.
842 funds tracked by Wall St. Rank held Halliburton as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.